Shete Omprakash, Ghosh Tarini Shankar
Department of Computational Biology, Indraprastha Institute of Information Technology Delhi, New Delhi, Delhi, India; email:
Annu Rev Med. 2025 Jan;76(1):95-114. doi: 10.1146/annurev-med-051223-031809. Epub 2025 Jan 16.
The human microbiome is a sensor and modulator of physiology and homeostasis. Remarkable tractability underpins the promise of therapeutic manipulation of the microbiome. However, the definition of a normal or healthy microbiome has been elusive. This is in part due to the underrepresentation of minority groups and major global regions in microbiome studies to date. We review studies of the microbiome in different populations and highlight a commonality among health-associated microbiome signatures along with major drivers of variation. We also provide an overview of microbiome-associated therapeutic interventions for some widespread, widely studied diseases. We discuss sources of bias and the challenges associated with defining population-specific microbiome reference bases. We propose a roadmap for defining normal microbiome references that can be used for population-customized microbiome therapeutics and diagnostics.
人类微生物组是生理和体内平衡的传感器及调节器。显著的可操作性为微生物组治疗性操控带来了希望。然而,正常或健康微生物组的定义一直难以捉摸。部分原因在于,迄今为止微生物组研究中少数群体和主要全球区域的代表性不足。我们回顾了不同人群中微生物组的研究,并强调了与健康相关的微生物组特征之间的共性以及变异的主要驱动因素。我们还概述了针对一些广泛研究的常见疾病的微生物组相关治疗干预措施。我们讨论了偏差来源以及与定义特定人群微生物组参考基准相关的挑战。我们提出了一个定义正常微生物组参考的路线图,可用于针对人群定制的微生物组治疗和诊断。